blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1260229

EP1260229 - Anti-autoimmune composition comprising inhibitors of growth hormone-releasing factor activity [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  31.08.2007
Database last updated on 04.06.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Dainippon Sumitomo Pharma Co., Ltd.
6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi
Osaka 541 / JP
For all designated states
Sumitomo Chemical Company, Limited
27-1, Shinkawa 2-chome, Chuo-ku
Tokyo 104-8260 / JP
[N/P]
Former [2006/06]For all designated states
Dainippon Sumitomo Pharma Co., Ltd.
6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi
Osaka 541 / JP
For all designated states
Sumitomo Chemical Company, Limited
27-1, Shinkawa 2-chome, Chuo-ku
Tokyo 104-8260 / JP
Former [2005/01]For all designated states
SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
2-8, Dosho-machi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
For all designated states
Sumitomo Chemical Company, Limited
27-1, Shinkawa 2-chome, Chuo-ku
Tokyo 104-8260 / JP
Former [2003/11]For all designated states
SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
2-8, Dosho-machi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
For all designated states
SUMITOMO CHEMICAL COMPANY LIMITED
5-33, Kitahama 4-chome, Chuo-ku
Osaka-shi, Osaka 541-0041 / JP
Former [2002/48]For all designated states
Sumitomo Pharmaceuticals Company, Limited
2-8, Doshomachi 2-chome, Chuo-ku
Osaka 541-8510 / JP
For all designated states
Sumitomo Chemical Company, Limited
5-33 Kitahama 4-chome, Chuo-ku
Osaka-shi, Osaka-fu / JP
Inventor(s)01 / Ikushima, Hideto
5-3, Minamishimizu-cho 3-chome
Sakai-shi, Osaka-fu / JP
 [2002/48]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2002/48]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date02011048.217.05.2002
[2002/48]
Priority number, dateJP2001014860718.05.2001         Original published format: JP 2001148607
[2002/48]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1260229
Date:27.11.2002
Language:EN
[2002/48]
Type: A3 Search report 
No.:EP1260229
Date:11.12.2002
[2002/50]
Search report(s)(Supplementary) European search report - dispatched on:EP24.10.2002
ClassificationIPC:A61K38/25, G01N33/50, A61P19/02, A61P21/00, A61P37/00, // A61K39/395, A61K31/7088, A61K48/00
[2002/48]
CPC:
G01N33/502 (EP,US); A61K38/25 (EP,US); A61P19/02 (EP);
A61P21/00 (EP); A61P37/00 (EP); G01N33/5008 (EP,US);
G01N33/564 (EP,US); G01N33/74 (EP,US); G01N2500/02 (EP,US);
G01N2500/20 (EP,US); G01N2800/24 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/48]
TitleGerman:Anti-Autoimmunpräparat das Inhibitoren der Aktivität von Wachstumshormon freisetzenden-Faktor enthält[2002/48]
English:Anti-autoimmune composition comprising inhibitors of growth hormone-releasing factor activity[2002/48]
French:Composition anti-autoimmunité comprenant des inhibiteurs de l'activité du facteur libérant l'hormone de croissance[2002/48]
Examination procedure10.03.2003Examination requested  [2003/19]
29.06.2005Despatch of a communication from the examining division (Time limit: M06)
09.01.2006Reply to a communication from the examining division
28.11.2006Communication of intention to grant the patent
11.04.2007Application deemed to be withdrawn, date of legal effect  [2007/40]
15.05.2007Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2007/40]
Fees paidRenewal fee
28.05.2004Renewal fee patent year 03
31.05.2005Renewal fee patent year 04
31.05.2006Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.200706   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]  - GIUSTINA ANDREA ET AL, "Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1997), Database accession no. PREV199799520115, XP002216120 [Y] 1-16,18-20 * abstract *
 [DY]  - ZARANDI M ET AL, "SYNTHESIS AND BIOLOGICAL ACTIVITIES OF HIGHLY POTENT ANTAGONISTS OF GROWTH HORMONE-RELEASING HORMONE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (19941201), vol. 91, ISSN 0027-8424, pages 12298 - 12302, XP002040642 [DY] 1-16,18-20 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.91.25.12298
    [ ] - METABOLISM CLINICAL AND EXPERIMENTAL, (1997), vol. 46, no. 4, ISSN 0026-0495, pages 382 - 387
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.